NFKB1 and CD4+/CD56+ hematodermic neoplasm: Although the activation of the NF-κB pathway, the disruption of cholesterol balance, and the destruction of the TCF4-/BRD4-dependent transcription network have been found in BPDCN, the above changes do not fully reveal the regulatory mechanisms involved in BPDCN development.